Lipid System Articles & Analysis
11 news found
This brand is driven by the insight that the next great therapeutic is waiting for a great delivery system, and its role is to provide high-quality, specialized components and expertise to make it happen. The BOC Sciences team will showcase its unique ability to synthesize and scale up essential drug delivery systems like lipid-based ...
The resulting vaccines validates our integrated approach using our unique skillset – from optimizing RNA payload, through formulation of the lipid nanoparticle delivery system to enhancing thermostability for mass manufacturing. ...
ByeTheRNA
(“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today the publication of a preclinical study demonstrating therapeutic capabilities of its SAT1 cancer marker in glioblastoma (GB) cells using an ionizable lipid nanoparticle. The study published as part of ...
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, has now expanded lipid system portfolio and launched a series of Sphingolipids products to support customers' scientific research. ...
CD Bioparticles now expands its lipid systems portfolio and offers a list of new prostaglandins products for the research community. ...
Ziphius Vaccines (the “Company” or “Ziphius”), a biopharmaceutical company developing transformative self-amplifying RNA (saRNA) based medicinal products for vaccine and therapeutic applications, and University of Antwerp today announce that they have entered into a collaboration agreement to research and develop a dynamic lipid library for optimized ...
In addition to disintegrant, CD Formulation also offers binder excipients, filler excipients, lubricant excipients, sweetener excipients, coating systems excipients, emulsifier excipients, lipid excipients, taste masking excipients, solubilizer excipients, active pharmaceutical ingredient excipients, carrier excipients, compaction excipients, dry powder ...
This prestigious award is for their work in developing lipid nanoparticle (LNP) systems to deliver cancer drugs to tumours and to enable RNA- and DNA-based drugs to be used therapeutically. Among other achievements, their work has resulted in the LNP system that enables COMRINATY®, the Pfizer/BioNTech COVID-19 mRNA vaccine. ...
In response to such a market trend, the management of CD Formulation earlier this month announces to offer customized synthesis for lipid excipients, which are used in lipid-based dosage forms for the enhancement of drug absorption or delivery. Although a number of technologies can help address formulation challenges, the lipid-based drug ...
Expands Pfizer’s access to lipid nanoparticle (LNP) formulation technology, offering a strong strategic fit with Pfizer’s mRNA strategy Pfizer gains option to license Acuitas’ LNP technology for up to 10 targets for vaccine or therapeutic development Pfizer Inc. (NYSE: PFE) and Acuitas Therapeutics, a company focused on developing lipid ...
In addition to binders, CD Formulation also offers disintegrant excipients, filler excipients, lubricant excipients, sweetener excipients, coating systems excipients, emulsifier excipients, lipid excipients, taste masking excipients, solubilizer excipients, active pharmaceutical ingredient excipients, carrier excipients, compaction excipients, dry powder ...